1 3

Prism Peptides

Retatrutide

Retatrutide

β‚±1,800.00 PHP
β‚±1,800.00 PHP
Sale Sold out
MG
Set

πŸ”΄ IMPORTANT: Read Before Proceeding With Dosing

For research and educational use only.
Always follow correct reconstitution and injection practices to avoid avoidable side effects.

⚑ RETATRUTIDE

Triple Agonist β€’ Rapid Fat Loss β€’ Metabolic Optimization

Retatrutide is the most comprehensive metabolic peptide currently under study, activating three key hormonal pathways involved in fat loss, metabolic balance, and energy regulation:

  • GLP-1 β†’ appetite suppression, insulin regulation
  • GIP β†’ glucose control, fat metabolism
  • Glucagon β†’ energy expenditure, lipolysis (fat breakdown)

By combining GLP-1, GIP, and glucagon agonism, Retatrutide advances beyond Semaglutide and Tirzepatide, delivering faster and deeper fat loss with broad systemic benefits.

βš™οΈ Mechanism of Action

Pathway Effect Outcome
GLP-1 Slows gastric emptying, reduces appetite Eat less, feel fuller
GIP Enhances insulin release, improves glucose tolerance Better carb handling & energy balance
Glucagon Increases metabolic rate, triggers fat oxidation Faster fat loss, higher energy use

πŸ“Š Clinical Effectiveness

Peptide Receptor Targets Average Weight Loss Duration
Semaglutide GLP-1 17% 68 weeks
Tirzepatide GLP-1 + GIP 24.7% 72 weeks
Retatrutide GLP-1 + GIP + Glucagon 17.5% 24 weeks
26.2% 48 weeks

➑️ Retatrutide currently shows the most rapid and sustained fat loss in clinical studies.

✨ Additional Benefits

  • Anti-inflammatory: may support rheumatoid arthritis & IBD
  • Collagen support: improves tone, elasticity & skin tightening post-weight loss
  • Wound healing: supports tissue recovery after injury
  • Angiogenesis: promotes new blood vessel growth β†’ better circulation
  • Muscle regeneration: activates satellite cells for recovery & repair

πŸ§ͺ Emerging Therapeutic Applications

(under investigation β€” research evolving)

Category Potential Benefit
Cardiovascular Improved cholesterol, hypertension & inflammation markers
Liver Promising for NAFLD reversal
Neurological Parkinson’s / Alzheimer’s research
Sleep & Addiction Sleep apnea & substance use disorder studies

⚠️ Possible Side Effects

Common (mild–moderate, dose-dependent):

  • Nausea, vomiting
  • Constipation or diarrhea
  • Headache, indigestion
  • Abdominal discomfort
  • Reduced appetite
  • Dehydration

Rare but Serious:

  • Gallbladder disease
  • Pancreatitis
  • Intestinal blockages
  • Gastroparesis (delayed stomach emptying)Kidney strain linked to dehydration

➑️ Side effects typically improve with hydration, slower titration, and nighttime dosing.

πŸ’‘ Side-Effect Management

Issue Strategy
Nausea Dose at night, smaller meals
Constipation Fiber + electrolytes
Appetite too low Prioritize protein first
Strong adverse effects Increase dose more slowly
High GI sensitivity Avoid heavy & greasy foods

🚫 Contraindications β€” Do NOT Use If:

  • Pregnant or nursing
  • Severe GI disorders (Crohn’s, IBD)Advanced liver disease or chronic kidney disease
  • Active or family history of thyroid cancer / MEN-2
  • Hypersensitivity to peptide-based medications

πŸ’‰ General Dosing Guidelines

  • Inject once weekly β€” same day every week
  • Remain at each dose β‰₯ 4 weeks
  • Increase only when progress plateaus
  • Start dose depends on prior GLP use:
Experience Starting Dose
Never used GLP-1/GIP 2 mg weekly
Used GLP previously & escalated at least once 4 mg weekly

➑️ If still losing weight at your current dose β†’ stay there until needed.

πŸ’‰ Reconstitution & Dosing Protocols

Subcutaneous Administration β€” Dose Once Weekly (every 7 days)
Stay minimum 4 weeks per dose level before increasing.
If still losing at your current dose β†’ you may stay longer before titrating up.

πŸ”Ή How to Determine Your Starting Dose

  • New to GLP-based peptides: start 2 mg weekly
  • Previously on a GLP and increased dose at least once: start 4 mg weekly

Dose at night if experiencing nausea, indigestion, or dizziness.

βœ… Retatrutide Reconstitution & Unit Conversion

Quick Conversion Rule:
Units needed = (Desired mg Γ· mg-per-unit)

πŸ§ͺ Retatrutide β€” 10 mg vial

Mix with: 1 mL (100 units) BAC water
Final concentration: 1 mg = 10 units

Dose Units
2 mg 20 units
4 mg 40 units
6 mg 60 units
8 mg 80 units
10 mg 100 units

πŸ§ͺ Retatrutide β€” 20 mg vialΒ 

Mix with: 2 mL (200 units) BAC water
Final concentration: 1 mg = 10 units (same as 10 mg vial β€” just double volume)

Dose Units
2 mg 20 units
4 mg 40 units
6 mg 60 units
8 mg 80 units
10 mg 100 units
12 mg 120 units
15 mg 150 units
20 mg 200 units

βœ” This format keeps the same units-per-mg as the 10 mg vial, making titration easier
βœ” Best choice if you want longer use between reconstitution cycles
βœ” Recommended for users reacting strongly at higher concentration (less sting)

πŸ§ͺ Retatrutide β€” 30 mg vial

Mix with: 2.5 mL (250 units) BAC water
Final concentration: 1 mg β‰ˆ 8.3 units

Dose Units
2 mg 16 units
4 mg 34 units
6 mg 50 units
8 mg 66 units
10 mg 84 units
12 mg 100 units

πŸ§ͺ Retatrutide β€” 40 mg vial

Mix with: 3 mL (300 units) BAC water
Final concentration: 1 mg = 7.5 units

Dose Units
2 mg 15 units
4 mg 30 units
6 mg 45 units
8 mg 60 units
10 mg 75 units
12 mg 90 units

⭐ Which Concentration Should I Choose?

Vial BAC Added Concentration Why Choose It
10 mg 1 mL Most concentrated Smallest injection volume
20 mg 2 mL Medium ← Recommended Easiest math, smoother comfort
30 mg 2.5 mL Less concentrated Longer-term vial usage
40 mg 3 mL Least concentrated Best for sensitive injectors

This chart uses Retatrutide 20 mg reconstituted with 2 mL BAC water
(1 mg = 10 units) β€” the easiest math for weekly use.

πŸ’‰ Retatrutide Weekly Titration Schedule

Dose once every 7 days β€” stay on each step β‰₯ 4 weeks
➑️ If still losing weight at your current dose β†’ remain until plateau
➑️ Increase only when needed for continued progress

πŸ”° Beginner Schedule (No prior GLP use)

(slow & gentle β€” lowest side-effect risk)

Weeks Weekly Dose Units Notes
1–4 2 mg 20 units Initial adaptation / appetite suppression begins
5–8 4 mg 40 units Increased satiety, fat loss ramps
9–12 6 mg 60 units Moderate therapeutic range
13–16 8 mg 80 units Strong appetite control
17+ 10 mg 100 units Go here only if needed

➑️ Most users do not need to exceed 8 mg if progressing steadily.

⚑ Intermediate Schedule (Prior GLP exposure)

(for users who already tolerated Semaglutide/Tirzepatide)

Weeks Weekly Dose Units Notes
1–4 4 mg 40 units Easier transition from prior GLP
5–8 6 mg 60 units Metabolic acceleration
9–12 8 mg 80 units Max appetite blocking & fat oxidation
13–16 10 mg 100 units For plateaus or stalled progress

➑️ If nausea / indigestion returns β†’ drop back one level.

πŸš€ Advanced Schedule (High tolerance, aggressive cut)

(ONLY if side effects are minimal and researcher experience is high)

Weeks Weekly Dose Units Notes
1–4 4 mg 40 units Base activation
5–8 6 mg 60 units Rapid fat loss onset
9–12 8 mg 80 units Main working phase
13–16 10 mg 100 units Push phase β€” expect stronger appetite suppression
17–20 12 mg 120 units Short-term max phase (not required for all)**

➑️ 12 mg should only be used if absolutely necessary.
➑️ Most clinical benefit occurs between 6–10 mg.

🧠 Side-Effect Adaptive Adjustment

Use this if symptoms flare:

Symptom Adjustment
Nausea / vomiting Dose at night β†’ reduce 2 mg β†’ increase hydration
Constipation Add fiber & electrolytes β†’ do NOT increase dose until resolved
Fatigue Increase protein intake β†’ 1–2 g/kg/day
Plateau Stay at current dose 2–4 more weeks before stepping up
Injection discomfort Add 20–50 units of BAC water to syringe to dilute

πŸ’‘ Stacking Suggestions by Phase

Phase Stack Why
Weeks 1–4 BPC-157 GI relief, gut adaptation
Weeks 5–8 AOD-9604 Increases fat mobilization
Weeks 9–12 Tesamorelin Visceral fat + muscle preservation
Weeks 12+ GHK-Cu Skin tightening after fat loss

πŸ”₯ Cagrilintide can be added at any stage for enhanced satiety + hunger control
(dose on separate day β€” slow titration)

🎯 Quick Reference

  • 1 mg = 10 units
  • Increase only after 4+ weeks at each doseHigher dose β‰  always better β€” progress > power
  • If losing steadily, don’t increase
View full details